In addition, we confirmed that the levels of phosphorylated FAK and FA-related proteins, such as p-Src and paxillin, were significantly increased in VSMCs treated by both forms of PAH (Fig. 6c). This evidence concerns the gene PXN and pulmonary arterial hypertension.